-
Something wrong with this record ?
HCV Elimination in Central Europe with Particular Emphasis on Microelimination in Prisons
R. Flisiak, D. Zarębska-Michaluk, E. Ciupkeviciene, S. Drazilova, S. Frankova, I. Grgurevic, B. Hunyady, P. Jarcuska, L. Kupčinskas, M. Makara, G. Saulite-Vanaga, M. Simonova, J. Sperl, I. Tolmane, A. Vince
Language English Country Switzerland
Document type Journal Article, Review
NLK
Directory of Open Access Journals
from 2009
Free Medical Journals
from 2009
PubMed Central
from 2009
Europe PubMed Central
from 2009
ProQuest Central
from 2009-01-01
Open Access Digital Library
from 2009-01-01
Open Access Digital Library
from 2009-01-01
Health & Medicine (ProQuest)
from 2009-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2009
PubMed
35336889
DOI
10.3390/v14030482
Knihovny.cz E-resources
- MeSH
- COVID-19 * epidemiology prevention & control MeSH
- Hepatitis C * diagnosis epidemiology prevention & control MeSH
- Humans MeSH
- Pandemics prevention & control MeSH
- Prisons MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Review MeSH
- Geographicals
- Europe MeSH
In 2016, the WHO announced a plan to eliminate viral hepatitis as a public health threat by 2030. In this narrative review, experts from Bulgaria, Croatia, the Czech Republic, Hungary, Latvia, Lithuania, Poland and Slovakia assessed the feasibility of achieving the WHO 2030 target for HCV infections in Central Europe. They focused mainly on HCV micro-elimination in prisons, where the highest incidence of HCV infections is usually observed, and the impact of the COVID-19 pandemic on the detection and treatment of HCV infections. According to the presented estimates, almost 400,000 people remain infected with HCV in the analyzed countries. Interferon-free therapies are available ad libitum, but the number of patients treated annually in the last two years has halved compared to 2017-2019, mainly due to the COVID-19 pandemic. None of the countries analyzed had implemented a national HCV screening program or a prison screening program. The main reason is a lack of will at governmental and prison levels. None of the countries analyzed see any chance of meeting the WHO targets for removing viral hepatitis from the public threat list by 2030, unless barriers such as a lack of political will and a lack of screening programs are removed quickly.
1st Department of Internal Medicine University of Pécs H7624 Pécs Hungary
Department of Gastroenterolgy Somogy Megyei Kaposi Mór Oktató Kórház H7400 Kaposvár Hungary
Department of Gastroenterology Lithuanian University of Health Sciences LT50061 Kaunas Lithuania
Department of Infectious Diseases Jan Kochanowski University 25 317 Kielce Poland
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22019355
- 003
- CZ-PrNML
- 005
- 20250402154123.0
- 007
- ta
- 008
- 220720s2022 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/v14030482 $2 doi
- 035 __
- $a (PubMed)35336889
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Flisiak, Robert $u Department of Infectious Diseases and Hepatology, Medical University of Białystok, 15-540 Białystok, Poland $1 https://orcid.org/0000000333941635
- 245 10
- $a HCV Elimination in Central Europe with Particular Emphasis on Microelimination in Prisons / $c R. Flisiak, D. Zarębska-Michaluk, E. Ciupkeviciene, S. Drazilova, S. Frankova, I. Grgurevic, B. Hunyady, P. Jarcuska, L. Kupčinskas, M. Makara, G. Saulite-Vanaga, M. Simonova, J. Sperl, I. Tolmane, A. Vince
- 520 9_
- $a In 2016, the WHO announced a plan to eliminate viral hepatitis as a public health threat by 2030. In this narrative review, experts from Bulgaria, Croatia, the Czech Republic, Hungary, Latvia, Lithuania, Poland and Slovakia assessed the feasibility of achieving the WHO 2030 target for HCV infections in Central Europe. They focused mainly on HCV micro-elimination in prisons, where the highest incidence of HCV infections is usually observed, and the impact of the COVID-19 pandemic on the detection and treatment of HCV infections. According to the presented estimates, almost 400,000 people remain infected with HCV in the analyzed countries. Interferon-free therapies are available ad libitum, but the number of patients treated annually in the last two years has halved compared to 2017-2019, mainly due to the COVID-19 pandemic. None of the countries analyzed had implemented a national HCV screening program or a prison screening program. The main reason is a lack of will at governmental and prison levels. None of the countries analyzed see any chance of meeting the WHO targets for removing viral hepatitis from the public threat list by 2030, unless barriers such as a lack of political will and a lack of screening programs are removed quickly.
- 650 12
- $a COVID-19 $x epidemiologie $x prevence a kontrola $7 D000086382
- 650 12
- $a hepatitida C $x diagnóza $x epidemiologie $x prevence a kontrola $7 D006526
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a pandemie $x prevence a kontrola $7 D058873
- 650 _2
- $a věznice $7 D011330
- 651 _2
- $a Evropa $x epidemiologie $7 D005060
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Zarębska-Michaluk, Dorota $u Department of Infectious Diseases, Jan Kochanowski University, 25-317 Kielce, Poland $1 https://orcid.org/0000000309381084
- 700 1_
- $a Ciupkeviciene, Egle $u Department of Gastroenterology, Lithuanian University of Health Sciences, LT50061 Kaunas, Lithuania
- 700 1_
- $a Drazilova, Sylvia $u 2nd Department of Internal Medicine, L Pasteur University Hospital and PJ Safarik University, Faculty of Medicine, 04011 Kosice, Slovakia
- 700 1_
- $a Fraňková, Soňa $u Department of Hepatogastroenterology, Institute for Clinical and Experimental Medicine, 14021 Prague, Czech Republic $1 https://orcid.org/0000000214625920 $7 xx0329475
- 700 1_
- $a Grgurevic, Ivica $u Department of Gastroenterology, Hepatology and Clinical Nutrition, University of Zagreb, University Hospital Dubrava, 10000 Zagreb, Croatia $1 https://orcid.org/0000000305203483
- 700 1_
- $a Hunyady, Bela $u Department of Gastroenterolgy, Somogy Megyei Kaposi Mór Oktató Kórház, H7400 Kaposvár, Hungary $u First Department of Internal Medicine, University of Pécs, H7624 Pécs, Hungary
- 700 1_
- $a Jarcuska, Peter $u 2nd Department of Internal Medicine, L Pasteur University Hospital and PJ Safarik University, Faculty of Medicine, 04011 Kosice, Slovakia
- 700 1_
- $a Kupčinskas, Limas $u Department of Gastroenterology, Lithuanian University of Health Sciences, LT50061 Kaunas, Lithuania $1 https://orcid.org/0000000286899023
- 700 1_
- $a Makara, Michael $u Central Hospital of Southern Pest National Institute of Hematology and Infectious Diseases, Saint Laszlo Hospital, 5-7. Albert Florian Street, H1097 Budapest, Hungary
- 700 1_
- $a Saulite-Vanaga, Gunita $u Out-Patient Department, Riga East University Hospital, Latvian Center of Infectious Diseases, LV1013 Riga, Latvia
- 700 1_
- $a Simonova, Marieta $u Department of HPB Surgery and Transplantology, Clinic of Gastroenterology, Military Medical Academy, 1606 Sofia, Bulgaria
- 700 1_
- $a Sperl, Jan $u Department of Hepatogastroenterology, Institute for Clinical and Experimental Medicine, 14021 Prague, Czech Republic $1 https://orcid.org/0000000186192610 $7 xx0071614
- 700 1_
- $a Tolmane, Ieva $u Out-Patient Department, Riga East University Hospital, Latvian Center of Infectious Diseases, LV1013 Riga, Latvia
- 700 1_
- $a Vince, Adriana $u Department of Infectious Diseases, Medical School University of Zagreb, University Hospital of Infectious Diseases, 10000 Zagreb, Croatia
- 773 0_
- $w MED00177099 $t Viruses $x 1999-4915 $g Roč. 14, č. 3 (2022)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/35336889 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220720 $b ABA008
- 991 __
- $a 20250402154119 $b ABA008
- 999 __
- $a ok $b bmc $g 1822800 $s 1170598
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2022 $b 14 $c 3 $e 20220226 $i 1999-4915 $m Viruses $n Viruses $x MED00177099
- LZP __
- $a Pubmed-20220720